Detection reagents for the Custom Productivity and Bispecific Heterodimer Assays are fluorescent molecules that bind to the secreted protein of interest and are used to quantify the amount of this protein produced by the cells being assayed.
Overview of the Opto CLD 2.0 workflow and representative results.
Dr. James Rothman, Nobel Laureate hosts an in-depth discussion with distinguished guests, Dr. Jennitte Stevens from Amgen, Dr. Gregory Bleck from Catalent-Biologics, and Dr. Trent Munro from the University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2.
Hear from BLI experts Renee Tobias and Anupam Singhal about the unique benefits to leveraging a single platform for both the identification of promising candidates and the production of leading therapeutic molecules.